Theodorescu D - Search Results

1

Development of Novel Aptamer-Based Targeted Chemotherapy for Bladder Cancer.

Wang Y, Zhang Y, Li PC, Guo J, Huo F, Yang J, Jia R, Wang J, Huang Q, Theodorescu D, Yu H, Yan C. Wang Y, et al. Among authors: theodorescu d. Cancer Res. 2022 Mar 15;82(6):1128-1139. doi: 10.1158/0008-5472.CAN-21-2691. Cancer Res. 2022. PMID: 35064018 Free PMC article.

2

Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.

Coblentz TR, Mills SE, Theodorescu D. Coblentz TR, et al. Among authors: theodorescu d. Cancer. 2001 Apr 1;91(7):1284-90. Cancer. 2001. PMID: 11283928

3

Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.

Fulmer BR, Bissonette EA, Petroni GR, Theodorescu D. Fulmer BR, et al. Among authors: theodorescu d. Cancer. 2001 Jun 1;91(11):2046-55. doi: 10.1002/1097-0142(20010601)91:11<2046::aid-cncr1231>3.0.co;2-w. Cancer. 2001. PMID: 11391584

4

Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.

Seraj MJ, Thomas AR, Chin JL, Theodorescu D. Seraj MJ, et al. Among authors: theodorescu d. Clin Cancer Res. 2001 Jun;7(6):1516-22. Clin Cancer Res. 2001. PMID: 11410485

5

Profiling the evolution of human metastatic bladder cancer.

Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D. Nicholson BE, et al. Among authors: theodorescu d. Cancer Res. 2004 Nov 1;64(21):7813-21. doi: 10.1158/0008-5472.CAN-04-0826. Cancer Res. 2004. PMID: 15520187

6

Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.

Copp HL, Chin JL, Conaway M, Theodorescu D. Copp HL, et al. Among authors: theodorescu d. Cancer. 2006 Jul 1;107(1):60-6. doi: 10.1002/cncr.21953. Cancer. 2006. PMID: 16691580 Free article. Clinical Trial.

7

Prediction of muscle-invasive bladder cancer using urinary proteomics.

Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg JU, Conaway MR, Mischak H, Theodorescu D. Schiffer E, et al. Among authors: theodorescu d. Clin Cancer Res. 2009 Aug 1;15(15):4935-43. doi: 10.1158/1078-0432.CCR-09-0226. Epub 2009 Jul 14. Clin Cancer Res. 2009. PMID: 19602546

8

Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy.

Williams PD, Cheon S, Havaleshko DM, Jeong H, Cheng F, Theodorescu D, Lee JK. Williams PD, et al. Among authors: theodorescu d. Cancer Res. 2009 Nov 1;69(21):8302-9. doi: 10.1158/0008-5472.CAN-09-0798. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843853 Free PMC article.

9

Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.

Thomas S, Overdevest JB, Nitz MD, Williams PD, Owens CR, Sanchez-Carbayo M, Frierson HF, Schwartz MA, Theodorescu D. Thomas S, et al. Among authors: theodorescu d. Cancer Res. 2011 Feb 1;71(3):832-41. doi: 10.1158/0008-5472.CAN-10-0730. Epub 2010 Dec 10. Cancer Res. 2011. PMID: 21148751 Free PMC article.

10

CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.

Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D. Overdevest JB, et al. Among authors: theodorescu d. Cancer Res. 2011 Jun 1;71(11):3802-11. doi: 10.1158/0008-5472.CAN-11-0519. Epub 2011 Apr 11. Cancer Res. 2011. PMID: 21482678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page